Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Virgin Coconut Oil (VCO) contains multiple compounds which have antibacterial, antiviral, and
immunomodulatory properties. The role of VCO as an antivirus to treat COVID-19 requires
further studies. A previous study has investigated the used of 30 ml of VCO to healthy
volunteers for a month and reported no side effect. Here the investigators conduct a pilot
trial to investigate the effect of VCO towards the clinical outcomes of COVID-19 patients in
Indonesia.